CDEK
← All organizations

Angelini

For profitContributed to NME

Also known as: ANGELINI PHARMA | Angelini Pharma Portugal, Unipessoal, Lda | Aziende Chimiche Riunite Angelini Francesco S.p.A

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jan 9, 2003

First marketed drug

Feb 2, 2010

Last known activity

Apr 13, 2025

Timeline

1910s

  1. Jan 1, 1919

    Angelini— Founded

2000s

  1. Jan 1, 2000

    Amuchina— Acquired

2010s

  1. Feb 2, 2010

    trazodone— NDA Secondary Org

2020s

  1. Jan 3, 2021

    Arvelle— Acquired

Drugs by trial phase (33 distinct, 70 trials)

Indications

Approved for

Studied for

Marketed drugs (2)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (28)

Details

Founded
Ancona, IT Jan 1, 1919
Last known activity
Apr 13, 2025

Designations held

  • Priority review